These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20523987)

  • 1. Activation of P-glycoprotein (Pgp)-mediated drug efflux by extracellular acidosis: in vivo imaging with 68Ga-labelled PET tracer.
    Thews O; Dillenburg W; Fellner M; Buchholz HG; Bausbacher N; Schreckenberger M; Rösch F
    Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1935-42. PubMed ID: 20523987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET imaging of the impact of extracellular pH and MAP kinases on the p-glycoprotein (Pgp) activity.
    Thews O; Dillenburg W; Rösch F; Fellner M
    Adv Exp Med Biol; 2013; 765():279-286. PubMed ID: 22879045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing p-glycoprotein (Pgp) activity in vivo utilizing 68Ga-Schiff base complexes.
    Fellner M; Dillenburg W; Buchholz HG; Bausbacher N; Schreckenberger M; Renz F; Rösch F; Thews O
    Mol Imaging Biol; 2011 Oct; 13(5):985-94. PubMed ID: 20824508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acidosis induces multi-drug resistance in rat prostate cancer cells (AT1) in vitro and in vivo by increasing the activity of the p-glycoprotein via activation of p38.
    Sauvant C; Nowak M; Wirth C; Schneider B; Riemann A; Gekle M; Thews O
    Int J Cancer; 2008 Dec; 123(11):2532-42. PubMed ID: 18729196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of extracellular acidity on the activity of P-glycoprotein and the cytotoxicity of chemotherapeutic drugs.
    Thews O; Gassner B; Kelleher DK; Schwerdt G; Gekle M
    Neoplasia; 2006 Feb; 8(2):143-52. PubMed ID: 16611407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-induced extracellular acidosis increases p-glycoprotein activity and chemoresistance in tumors in vivo via p38 signaling pathway.
    Thews O; Nowak M; Sauvant C; Gekle M
    Adv Exp Med Biol; 2011; 701():115-22. PubMed ID: 21445777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization of multidrug resistance in vivo.
    Hendrikse NH; Franssen EJ; van der Graaf WT; Vaalburg W; de Vries EG
    Eur J Nucl Med; 1999 Mar; 26(3):283-93. PubMed ID: 10079321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative small-animal PET evaluation of [11C]tariquidar, [11C]elacridar and (R)-[11C]verapamil for detection of P-glycoprotein-expressing murine breast cancer.
    Wanek T; Kuntner C; Bankstahl JP; Bankstahl M; Stanek J; Sauberer M; Mairinger S; Strommer S; Wacheck V; Löscher W; Erker T; Müller M; Langer O
    Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):149-59. PubMed ID: 21983837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by reactive oxygen species.
    Wartenberg M; Ling FC; Schallenberg M; Bäumer AT; Petrat K; Hescheler J; Sauer H
    J Biol Chem; 2001 May; 276(20):17420-8. PubMed ID: 11279018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of p38 MAPK diminishes doxorubicin-induced drug resistance associated with P-glycoprotein in human leukemia K562 cells.
    Chen Y; Zhao Y; Wang C; Xiao X; Zhou X; Xu G
    Med Sci Monit; 2012 Oct; 18(10):BR383-8. PubMed ID: 23018344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier.
    Sharma V; Prior JL; Belinsky MG; Kruh GD; Piwnica-Worms D
    J Nucl Med; 2005 Feb; 46(2):354-64. PubMed ID: 15695797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acidic environment leads to ROS-induced MAPK signaling in cancer cells.
    Riemann A; Schneider B; Ihling A; Nowak M; Sauvant C; Thews O; Gekle M
    PLoS One; 2011; 6(7):e22445. PubMed ID: 21818325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and preclinical evaluation of the radiolabeled P-glycoprotein inhibitor [(11)C]MC113.
    Mairinger S; Wanek T; Kuntner C; Doenmez Y; Strommer S; Stanek J; Capparelli E; Chiba P; Müller M; Colabufo NA; Langer O
    Nucl Med Biol; 2012 Nov; 39(8):1219-25. PubMed ID: 22981987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel gallium(III) complexes transported by MDR1 P-glycoprotein: potential PET imaging agents for probing P-glycoprotein-mediated transport activity in vivo.
    Sharma V; Beatty A; Wey SP; Dahlheimer J; Pica CM; Crankshaw CL; Bass L; Green MA; Welch MJ; Piwnica-Worms D
    Chem Biol; 2000 May; 7(5):335-43. PubMed ID: 10801474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the tumor microenvironment in the activity and expression of the p-glycoprotein in human colon carcinoma cells.
    Lotz C; Kelleher DK; Gassner B; Gekle M; Vaupel P; Thews O
    Oncol Rep; 2007 Jan; 17(1):239-44. PubMed ID: 17143504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratinocyte growth factor-2 stimulates P-glycoprotein expression and function in intestinal epithelial cells.
    Saksena S; Priyamvada S; Kumar A; Akhtar M; Soni V; Anbazhagan AN; Alakkam A; Alrefai WA; Dudeja PK; Gill RK
    Am J Physiol Gastrointest Liver Physiol; 2013 Mar; 304(6):G615-22. PubMed ID: 23328208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of extracellular acidosis on intracellular pH control and cell signaling in tumor cells.
    Riemann A; Ihling A; Schneider B; Gekle M; Thews O
    Adv Exp Med Biol; 2013; 789():221-228. PubMed ID: 23852498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hypoxia-related tumor acidosis on cytotoxicity of different chemotherapeutic drugs in vitro and in vivo.
    Thews O; Riemann A; Nowak M; Gekle M
    Adv Exp Med Biol; 2014; 812():51-58. PubMed ID: 24729214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
    Guo A; Marinaro W; Hu P; Sinko PJ
    Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multidrug transporter P-glycoprotein: a mediator of melanoma invasion?
    Colone M; Calcabrini A; Toccacieli L; Bozzuto G; Stringaro A; Gentile M; Cianfriglia M; Ciervo A; Caraglia M; Budillon A; Meo G; Arancia G; Molinari A
    J Invest Dermatol; 2008 Apr; 128(4):957-71. PubMed ID: 17943188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.